Livzon Pharmaceutical Group Inc. (SHE:000513)

SHE:000513 Revenue

Livzon Pharmaceutical Group had revenue of 2.32B CNY in the quarter ending September 30, 2026, a decrease of -18.44%. This brings the company's total for the last twelve months to 10.22B, down -13.70% year-over-year. In the year 2025, Livzon Pharmaceutical Group had annual revenue of 12.02B with 1.76% growth. That makes Livzon Pharmaceutical Group the 5,902nd largest company in the world by revenue and 790th in China.

• Revenue (ttm): 10.22B
• Revenue Growth: -13.70%
• P/S Ratio: 2.22
• Revenue / Employee: 1.15M
• Employees: 8,878
• Market Cap: 22.67B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 9.97B 83.8%
• Overseas 1.93B 16.2%

Fiscal year ended Dec 31, 2025 See the full SHE:000513 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.02B	208.01M	1.76%
Dec 31, 2024	11.81B	-617.70M	-4.97%
Dec 31, 2023	12.43B	-199.54M	-1.58%
Dec 31, 2022	12.63B	565.72M	4.69%
Jan 1, 2022	12.06B	1.54B	14.67%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error